May 2024

BioHarvest Sciences Reports First Quarter 2024 Financial Results

2024 /

Q1 2024 Revenue Increased 147% Year-over-Year to US$5.34 Million Exceeding Previous Guidance Management Expects Q2 2024 Revenue in the Range of US$5.7-6.0 Million Vancouver, British Columbia and Rehovot, Israel – May 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today reported […]

BioHarvest Sciences Reports First Quarter 2024 Financial Results Read More »

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION

2024 /

VANCOUVER, CANADA, and REHOVOT, ISRAEL, May 29, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) announces that it plans to consolidate (the “Consolidation”) its issued and outstanding common shares (“Common Shares”) on the basis of thirty-five (35) pre-Consolidation Common Shares for every one (1) post-Consolidation Common Share. Pursuant to Section 4.6(8) of

BIOHARVEST SCIENCES INC. ANNOUNCES SHAREHOLDER APPROVAL OF SHARE CONSOLIDATION Read More »

img

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time

2024 /

Vancouver, British Columbia and Rehovot, Israel – May 1, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, May 2nd to discuss recently announced milestone achievements, including full year 2023

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 p.m. Eastern Time Read More »